ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105509 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105509; 2) Community: the network communities that were significantly associated with the response to NSC 105509; 3) Molecule: the relationships between components within communities and NSC 105509; 4) MDR: the compounds that were significantly associated with the NSC 105509.

NSC Compound Enrichment Correlation
NSC 641228 4-(2-fluorophenyl)-2,4-dioxo-3-(3-oxo-1,3-dihydroisobenzofuran-1-yl)-N-o-tolylbutanamide 0.0462077035966078 -0.080522079
NSC 671107 Null 0.0462077035966078 -0.074440936
NSC 704561 Null 0.0462077035966078 -0.072178426
NSC 734148 2-(4-Chloro-benzenesulfonylimino)-imidazolidine-1-carbodithi oic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4] thiadiazol-7-yl ester 0.0462077035966078 -0.16544133
NSC 735331 Null 0.0462077035966078 -0.11927383
NSC 743691 Null 0.0462077035966078 -0.012257274
NSC 126771 Dichloroallyl lawsone 0.0462077035966084 -0.25113845
NSC 376265 Piperazine-1-carbothioic acid, 4-cycloheptyl-, [1-(2-pyridyl)ethylidene]hydrazide 0.0462077035966084 -0.13013074
NSC 46691 Null 0.0462077035966084 0.22873869
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0462077035966084 -0.098418897
Total:57  Current:53    [First] [Prev] [Next] [Last]